Effects of omega-3 polyunsaturated fatty acid supplementation on parameters of glycaemic control in people with type 1 diabetes: a double-blind, randomised, placebo-controlled trial.

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Acid Supplementation

Effects of omega-3 polyunsaturated fatty acid supplementation on parameters of glycaemic control in people with type 1 diabetes: a double-blind, randomised, placebo-controlled trial

Proceedings of The Nutrition Society ◽

10.1017/s002966512000734x ◽

2020 ◽

Vol 79 (OCE3) ◽

Author(s):

L.L. O'Mahoney ◽

A.M. Alobaid ◽

R.A. Ajjan ◽

K.M. Birch ◽

N.M. Orsi ◽

...

Keyword(s):

Type 1 Diabetes ◽

Fatty Acid ◽

Glycaemic Control ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Acid Supplementation

Omega-3 polyunsaturated fatty acid supplementation versus placebo on vascular health, glycaemic control, and metabolic parameters in people with type 1 diabetes: a randomised controlled preliminary trial

Cardiovascular Diabetology ◽

10.1186/s12933-020-01094-5 ◽

2020 ◽

Vol 19 (1) ◽

Author(s):

Lauren L. O’Mahoney ◽

Gareth Dunseath ◽

Rachel Churm ◽

Mel Holmes ◽

Christine Boesch ◽

...

Keyword(s):

Type 1 Diabetes ◽

Fatty Acid ◽

Glycaemic Control ◽

Vascular Health ◽

Omega 3 ◽

Acid Supplementation ◽

Randomised Controlled

The effect of omega-3 polyunsaturated fatty acid supplementation on vascular structure, function, and inflammation in type 1 diabetes: a double-blind, randomised, placebo-controlled trial

Proceedings of The Nutrition Society ◽

10.1017/s0029665120007338 ◽

2020 ◽

Vol 79 (OCE3) ◽

Author(s):

L.L. O'Mahoney ◽

A.M. Alobaid ◽

R.A. Ajjan ◽

K.M. Birch ◽

N.M. Orsi ◽

...

Keyword(s):

Type 1 Diabetes ◽

Fatty Acid ◽

Structure Function ◽

Controlled Trial ◽

Vascular Structure ◽

Omega 3 ◽

Double Blind ◽

Fatty Acid Supplementation

The effect of omega-3 polyunsaturated fatty acid supplementation on vascular structure, function, and inflammation in type 1 diabetes: a double-blind, randomised, placebo-controlled trial.

10.26226/morressier.5ef37080b2a27f760262bb3e ◽

2020 ◽

Author(s):

Lauren O'Mahoney

Keyword(s):

Type 1 Diabetes ◽

Fatty Acid ◽

Structure Function ◽

Controlled Trial ◽

Vascular Structure ◽

Omega 3 ◽

Double Blind ◽

Fatty Acid Supplementation

Prenatal omega-3 fatty acid supplementation does not affect offspring telomere length and F2-isoprostanes at 12 years: A double blind, randomized controlled trial

Prostaglandins Leukotrienes and Essential Fatty Acids ◽

10.1016/j.plefa.2016.08.006 ◽

2016 ◽

Vol 112 ◽

pp. 50-55 ◽

Cited By ~ 12

Author(s):

V.H.L. See ◽

E. Mas ◽

S. Burrows ◽

N.J. O’Callaghan ◽

M. Fenech ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Fatty Acid ◽

Telomere Length ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Acid Supplementation ◽

Omega 3 Fatty Acid ◽

Randomized Controlled

Effects of omega-3 polyunsaturated fatty acid supplementation in patients with chronic chagasic cardiomyopathy: study protocol for a randomized controlled trial

Trials ◽

10.1186/1745-6215-14-379 ◽

2013 ◽

Vol 14 (1) ◽

pp. 379 ◽

Cited By ~ 9

Author(s):

Paula S Silva ◽

Gilberto Sperandio da Silva ◽

Andréa P de Souza ◽

Claudia SA Cardoso ◽

Cristiane A Fonseca ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Fatty Acid ◽

Study Protocol ◽

Controlled Trial ◽

Omega 3 ◽

Acid Supplementation ◽

Randomized Controlled ◽

Chagasic Cardiomyopathy

Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial

Clinical Nutrition ◽

10.1016/j.clnu.2014.06.005 ◽

2015 ◽

Vol 34 (3) ◽

pp. 388-393 ◽

Cited By ~ 39

Author(s):

Mansooreh Samimi ◽

Mehri Jamilian ◽

Zatollah Asemi ◽

Ahmad Esmaillzadeh

Keyword(s):

Fatty Acid ◽

Gestational Diabetes ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Insulin Metabolism ◽

Double Blind Placebo ◽

Acid Supplementation ◽

Omega 3 Fatty Acid

Chronic omega-3 fatty acid supplementation in type 1 diabetes

http://isrctn.com/ ◽

10.1186/isrctn40811115 ◽

2017 ◽

Cited By ~ 1

Author(s):

Matthew Campbell

Keyword(s):

Type 1 Diabetes ◽

Fatty Acid ◽

Omega 3 ◽

Acid Supplementation ◽

Omega 3 Fatty Acid

Effect of omega-3 (n−3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial

American Journal of Clinical Nutrition ◽

10.3945/ajcn.112.036319 ◽

2012 ◽

Vol 97 (1) ◽

pp. 37-44 ◽

Cited By ~ 56

Author(s):

Ahmed A Daak ◽

Kebreab Ghebremeskel ◽

Zahir Hassan ◽

Bakhita Attallah ◽

Haj H Azan ◽

...

Keyword(s):

Fatty Acid ◽

Sickle Cell ◽

Sickle Cell Anemia ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Acid Supplementation

Design and methods for the Better Resiliency Among Veterans and non-Veterans with Omega-3's (BRAVO) study: A double blind, placebo-controlled trial of omega-3 fatty acid supplementation among adult individuals at risk of suicide

Contemporary Clinical Trials ◽

10.1016/j.cct.2016.02.002 ◽

2016 ◽

Vol 47 ◽

pp. 325-333 ◽

Cited By ~ 4

Author(s):

Bernadette P. Marriott ◽

Joseph R. Hibbeln ◽

Therese K. Killeen ◽

Kathryn M. Magruder ◽

Kelly Holes-Lewis ◽

...

Keyword(s):

At Risk ◽

Fatty Acid ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Acid Supplementation ◽

Omega 3 Fatty Acid ◽

Design And Methods